Selected article for: "high incidence and immune response"
Author: Nigro, Ersilia; Perrotta, Fabio; Polito, Rita; D'Agnano, Vito; Scialò, Filippo; Bianco, Andrea; Daniele, Aurora
Title: Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways
  • Cord-id: y69u7mr2
  • Document date: 2020_11_28
    • ID: y69u7mr2
    Snippet: Coronavirus disease (COVID-19) is caused by SARS-CoV-2 virus, which can result in serious respiratory illnesses such as pneumonia leading to respiratory failure. It was first reported in Wuhan, Hubei, China, in December 2019 and rapidly spread globally, becoming a pandemic in March 2020. Among comorbidities observed in SARS-CoV-2 positive patients, hypertension (68.3%) and type 2-diabetes (30.1%) are the most frequent conditions. Although symptoms are highly heterogeneous (ranging from absence o
    Document: Coronavirus disease (COVID-19) is caused by SARS-CoV-2 virus, which can result in serious respiratory illnesses such as pneumonia leading to respiratory failure. It was first reported in Wuhan, Hubei, China, in December 2019 and rapidly spread globally, becoming a pandemic in March 2020. Among comorbidities observed in SARS-CoV-2 positive patients, hypertension (68.3%) and type 2-diabetes (30.1%) are the most frequent conditions. Although symptoms are highly heterogeneous (ranging from absence of symptoms to severe acute respiratory failure), patients with metabolic-associated diseases often experience worse COVID-19 outcomes. This review investigates the association between metabolic disorders and COVID-19 severity, exploring the molecular mechanisms potentially underlying this relationship and those that are responsible for more severe COVID-19 outcomes. In addition, the role of the main biological processes that may connect metabolic alterations to SARS-CoV-2 infection such as hyperglycemia, immune system deregulation, ACE-2 receptor modulation, and inflammatory response is described. The impact of metabolic disorders on the prognosis of COVID-19 has major implications in public health especially for countries affected by a high incidence of metabolic diseases.

    Search related documents:
    Co phrase search for related documents
    • absolute count and activation tissue factor: 1
    • absolute count and acute department: 1
    • absolute count and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • absolute count and acute sars respiratory syndrome cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • ace ace inhibitor and acute sars respiratory syndrome cov: 1
    • ace administration and acute lung injury: 1
    • ace administration and acute respiratory distress syndrome: 1
    • ace administration and acute sars respiratory syndrome cov: 1, 2
    • ace inhibitor and acute lung injury: 1, 2, 3, 4
    • ace inhibitor and acute respiratory distress syndrome: 1, 2, 3, 4, 5
    • ace inhibitor and acute sars respiratory syndrome cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • ace inhibitor and adaptive innate: 1
    • ace receptor and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • ace receptor and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace receptor and acute sars respiratory syndrome cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace receptor and acute viral respiratory infection: 1, 2
    • ace receptor and adaptive innate: 1, 2, 3
    • ace receptor and adaptive innate immune response: 1
    • activated receptors and adaptive innate immune response: 1